B
36.22
0.99 (2.81%)
| Previous Close | 35.23 |
| Open | 35.54 |
| Volume | 2,145,067 |
| Avg. Volume (3M) | 3,719,211 |
| Market Cap | 6,532,360,704 |
| Price / Earnings (TTM) | 65.85 |
| Price / Earnings (Forward) | 34.84 |
| Price / Sales | 0.580 |
| Price / Book | 3.59 |
| 52 Weeks Range | |
| Earnings Date | 28 Oct 2025 |
| Profit Margin | 0.48% |
| Operating Margin (TTM) | 1.77% |
| Diluted EPS (TTM) | 0.270 |
| Quarterly Revenue Growth (YOY) | 25.90% |
| Quarterly Earnings Growth (YOY) | 399.50% |
| Total Debt/Equity (MRQ) | 160.76% |
| Current Ratio (MRQ) | 1.74 |
| Operating Cash Flow (TTM) | 204.23 M |
| Levered Free Cash Flow (TTM) | -385.76 M |
| Return on Assets (TTM) | 4.39% |
| Return on Equity (TTM) | 2.74% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Mixed | |
| Stock | BrightSpring Health Services, I | Bullish | Bullish |
AIStockmoo Score
0.1
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | -3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 0.13 |
|
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 3.29% |
| % Held by Institutions | 97.60% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 42.00 (UBS, 15.96%) | Buy |
| Median | 39.00 (7.68%) | |
| Low | 31.00 (B of A Securities, -14.41%) | Buy |
| Average | 36.71 (1.35%) | |
| Total | 7 Buy | |
| Avg. Price @ Call | 31.60 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BMO Capital | 13 Nov 2025 | 40.00 (10.44%) | Buy | 31.75 |
| Wells Fargo | 12 Nov 2025 | 39.00 (7.68%) | Buy | 33.64 |
| 07 Oct 2025 | 33.00 (-8.89%) | Buy | 28.42 | |
| BTIG | 29 Oct 2025 | 41.00 (13.20%) | Buy | 34.05 |
| UBS | 29 Oct 2025 | 42.00 (15.96%) | Buy | 34.05 |
| 13 Oct 2025 | 35.00 (-3.37%) | Buy | 29.48 | |
| Mizuho | 17 Oct 2025 | 32.00 (-11.65%) | Buy | 29.73 |
| Morgan Stanley | 14 Oct 2025 | 32.00 (-11.65%) | Buy | 29.92 |
| B of A Securities | 10 Sep 2025 | 31.00 (-14.41%) | Buy | 28.08 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 28 Oct 2025 | Announcement | BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance |
| 20 Oct 2025 | Announcement | BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase |
| 20 Oct 2025 | Announcement | BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase |
| 20 Oct 2025 | Announcement | BrightSpring Health Services, Inc. Reports Preliminary Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance |
| 14 Oct 2025 | Announcement | BrightSpring Health Services Set to Join S&P SmallCap 600 |
| 08 Oct 2025 | Announcement | BrightSpring Health Services, Inc. to Announce Third Quarter 2025 Financial Results on October 31, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |